Where next for the A2 Milk (ASX:A2M) share price?

The A2 Milk Company Ltd (ASX:A2M) share price is down 42% over the last 12 months. Where are a2 Milk's shares heading from here?

The A2 Milk Company Ltd (ASX: A2M) share price has been well and truly out of form over the last 12 months.

During this time, the infant formula company's shares have lost 42% of their value.

A teacher in front of a classroom chalkboard filled with questionmarks, indicating share market uncertainty

Image source: Getty Images

Why is the a2 Milk share price underperforming?

The a2 Milk share price has come under significant pressure over the last 12 months due to significant weakness in the daigou channel.

In addition, management's failure to ascertain just how long this weakness would go on for has also weighed on its shares. This has led to the company downgrading its guidance for FY 2021 on two occasions.

Is this a buying opportunity?

Analysts at Goldman Sachs aren't sure that now is the time to invest and have just held firm with their neutral rating and $10.30 price target.

Commenting on its recent half year results, Goldman said: "Although management's guidance revision from Dec 2020 included a weaker CBEC channel, the decline was well ahead of GSe at -35.5%. EBITDA margins were impacted adversely by the mix impact from higher sales of lower margin China label products. Guidance for FY21 has been revised down by c. A$28-85.5mn at the top and bottom end of the prior range respectively on EBITDA."

What could get the a2 Milk share price heading higher?

Goldman notes that there is upside risk if a2 Milk experiences a quicker than expected recovery in the daigou channel.

It also suspects that the company's new CEO could provide a strategy update before the end of the financial year. If the market likes what it sees, it feels its shares could start rising.

Goldman explained: "Given his range of experience and capabilities, we believe incoming CEO, David Bortolussi, has the potential to make a material contribution to A2M's strategic execution and, potentially, longer term performance. However, the strategic redirection is unlikely to be revealed until the new CEO has had some time in the role. We anticipate a strategy update at some stage in 4Q21, which could present as a catalyst for the stock."

For now, though, Goldman appears to expect the a2 Milk share price to trade around its current level until the next catalyst appears. Hopefully for shareholders, this time it will be a positive one.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended A2 Milk. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ASX Share Market News

A little girl wearing wonky glasses checks out what's happening in the world on a mobile phone.
Broker Notes

Buy, hold, sell: Paladin Energy, Accent, Sigma Healthcare shares

Experts reveal the reasons behind their new ratings.

Read more »

A woman relaxes on a yellow couch with a book and cuppa, and looks pensively away as she contemplates the joy of earning passive income.
Opinions

3 reasons why I think this leading ASX 200 share is a buy

This underrated business could be a top buy today…

Read more »

Man in shirt and tie falls face first down stairs.
Record Lows

I think this ASX 200 stock looks like a bargain after hitting an all-time low: Here's why

The ASX shares fell another 8% on Tuesday.

Read more »

A woman looks excited as she fans out a wad of Aussie $100 notes.
Broker Notes

Macquarie predicts 90% upside and an 8% dividend yield for this ASX share

If the broker is right, this share will pay off nicely.

Read more »

Man working on a laptop from home.
ASX Share Market News

5 things to watch on the ASX 200 on Wednesday

It could be another tough session for Aussie investors on hump day.

Read more »

A woman sprints with a trail of fire blazing from her body.
Opinions

I hunted the ASX for shares with the potential to double. This one stood out

Do you have this ASX share in your investment portfolio?

Read more »

a doctor in white coat and stethoscope stands in front of a building holding an electronic device in his hands.
Healthcare Shares

ASX 200 healthcare shares rebound 57% in 5 months. Here's 1 to buy and 1 to sell: experts

It's time to take profits on one share, while the other has more growth left, say these experts.

Read more »

A fit woman in workout gear flexes her muscles with two bigger people flexing behind her, indicating growth.
Opinions

I wanted growth, not hype. Only 3 ASX shares passed my checks

One of these ASX shares is tipped to climb up to 38%.

Read more »